|
Search
Collections
Benchmarks
Upload document
Product
CHF5259
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
2 indications
Indication
Asthma
Indication
Chronic Obstructive Pulmonary Disease
Clinical trial
A Randomized, Double-blind, Positive and Placebo-controlled, Single-dose, Crossover Study of the Effects of CHF5993 pMDI (BDP/FF/GB) at the Proposed Therapeutic and Supratherapeutic Doses, on the Cardiovascular Safety in Healthy Subjects
Status: Completed
, Estimated PCD: 2023-10-13